North America Vitamin K2 Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Vitamin K2 Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Vitamin K2 Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Vitamin K2 Market Regional Analysis

6.2 North America Vitamin K2 Market Revenue 2020-2030 (US$ Million)

6.3 North America Vitamin K2 Market Forecast Analysis

7. North America Vitamin K2 Market Analysis – by Product

7.1 MK-4

7.1.1 Overview
7.1.2 MK-4: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 MK-7

7.2.1 Overview
7.2.2 MK-7: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Combination Drugs

7.3.1 Overview
7.3.2 Combination Drugs: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Vitamin K2 Market Analysis – by Dosage Forms

8.1 Capsules & Tablets

8.1.1 Overview
8.1.2 Capsules & Tablets: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Powder

8.2.1 Overview
8.2.2 Powder: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Oils

8.3.1 Overview
8.3.2 Oils: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Vitamin K2 Market Analysis – by Source

9.1 Natural

9.1.1 Overview
9.1.2 Natural: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Synthetic

9.2.1 Overview
9.2.2 Synthetic: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Vitamin K2 Market Analysis – by Application

10.1 Pharmaceuticals

10.1.1 Overview
10.1.2 Pharmaceuticals: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Nutraceuticals and Food

10.2.1 Overview
10.2.2 Nutraceuticals and Food: North America Vitamin K2 Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. North America Vitamin K2 Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Vitamin K2 Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 North America Vitamin K2 Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 US: North America Vitamin K2 Market Breakdown, by Product
11.2.1.1.2 US: North America Vitamin K2 Market Breakdown, by Dosage Forms
11.2.1.1.3 US: North America Vitamin K2 Market Breakdown, by Source
11.2.1.1.4 US: North America Vitamin K2 Market Breakdown, by Application

11.2.1.2 Canada: North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Canada: North America Vitamin K2 Market Breakdown, by Product
11.2.1.2.2 Canada: North America Vitamin K2 Market Breakdown, by Dosage Forms
11.2.1.2.3 Canada: North America Vitamin K2 Market Breakdown, by Source
11.2.1.2.4 Canada: North America Vitamin K2 Market Breakdown, by Application

11.2.1.3 Mexico : North America Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Mexico : North America Vitamin K2 Market Breakdown, by Product
11.2.1.3.2 Mexico : North America Vitamin K2 Market Breakdown, by Dosage Forms
11.2.1.3.3 Mexico : North America Vitamin K2 Market Breakdown, by Source
11.2.1.3.4 Mexico : North America Vitamin K2 Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Anderson Global Group LLC

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Balchem Corp

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 BASF SE

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Glanbia Plc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 International Flavors & Fragrances Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Koninklijke DSM NV

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Lesaffre et Cie SA

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Lonza Group AG

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Novozymes AS

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Vitamin K2 Market

Analysis - by Product (MK-4, MK-7, and Combination Drugs), Dosage Forms (Capsules & Tablets, Powder, and Oils), Source (Natural and Synthetic), and Application (Pharmaceuticals, Nutraceuticals and Food, and Others)